Histocompatibility Committee

Slides:



Advertisements
Similar presentations
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Advertisements

UNOS Update.  Updating 2012 Strategic plan  Planning for OPTN and UNOS Strategic Planning RegionsBoard Executive Committee /CAC Community.
Histocompatibility Bylaws Rewrite: Phase 2 Histocompatibility Committee Fall 2014.
OPTN OPTN Kidney Paired Donation Pilot Program Ruthanne L Hanto RN, MPH Program Manager, OPTN KPDPP Regions 4 Meeting May 11, 2012.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
IT Update November 12, Agenda  Opening RemarksJames Gleason  IT UpdateAlex Tulchinsky.
1 Region 10 Meeting Tim Taber, MD Regional Councillor.
1 National Webinar to Review Non-Discussion Agenda Fall 2015 Public Comment If you are logged into the webinar, please enter the audio PIN Please put your.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Fall 2014.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
OPTN Bylaws Substantive Rewrite of the Bylaws Addressing Review, Actions, and Due Process Sponsored by the Membership and Professional Standards Committee.
1 Revising Kidney Paired Donation Pilot Program Priority Points Kidney Transplantation Committee Fall 2015.
1 Proposal to Update the HLA Equivalency Tables Histocompatibility Committee Fall 2015.
1 Region 7 Meeting Julie Heimbach, MD Regional Councillor.
OPTN/UNOS HISTOCOMPATIBILITY COMMITTEE REPORT TO THE BOARD OF DIRECTORS JUNE 25-26, 2012 RICHMOND, VA Nancy L. Reinsmoen, PhD., Chair.
Improving the OPTN Policy Development Process Executive Committee Fall 2014.
1 OPTN/UNOS Histocompatibility Committee Fall 2015.
1 National Webinar to Review Non-Discussion Agenda Spring 2016 Public Comment If you are logged into the webinar, please enter the audio PIN Please put.
Histocompatibility Committee
Updating Primary Kidney Transplant Physician Requirements
Pediatric Transplantation Committee
Minority Affairs Committee
Revisions to Pediatric Emergency Membership Exception
Expedited Organ Placement Concept Paper
Guidance on Optimizing VCA Recovery from Deceased Donors
Histocompatibility Committee
Histocompatibility Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
OPO Committee Spring 2018.
Pediatric Transplantation Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Guidance for ABO Subtyping Organ Donors for Blood Groups A and AB
OPTN/UNOS Kidney Transplantation Committee
Addressing HLA Typing Errors
Membership and Professional Standards Committee
Histocompatibility Laboratory Bylaws and Policies Guidance Document
Histocompatibility Committee
Pediatric Transplantation Committee
Pediatric Transplantation Committee
Mark S. Orloff, MD Regional Councillor
Changes to HCC Criteria for Auto Approval
Vascularized Composite Allograft (VCA) Transplantation Committee
OPTN/UNOS Transplant Coordinators Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Histocompatibility Committee
Operations and Safety Committee
Kidney Transplantation Committee
Kidney Transplantation Committee
Membership & Professional Standards Committee (MPSC)
Pediatric Transplantation Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Membership & Professional Standards Committee
Pancreas Transplantation Committee
Kidney Transplantation Committee
Vascularized Composite Allograft Transplantation Committee Fall 2014
Nancy L. Reinsmoen, PhD, Chair
Elizabeth A. Pomfret, MD, PhD Regional Councillor
Region 8 Meeting Harvey Solomon, MD
Improving the Efficiency of Organ Placement
Histocompatibility Committee
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Membership & Professional Standards Committee (MPSC)
Histocompatibility Committee
VCA Committee Update Spring 2015.
Histocompatibility Committee
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Presentation transcript:

Histocompatibility Committee Fall 2016

Recent Public Comment Proposals Adding DQA1 Equivalency Table This proposal adds an HLA DQA1 equivalency table to policy that identifies the relationship between parent antigens and corresponding allelic subtypes. Board approved & pending implementation – target date is first quarter 2017

Policy Implementation Dates Histo Bylaws Rewrite: Phase 2 This proposal added the general supervisor to the list of laboratory key personnel. BOD approved, IT programming complete, waiting for OMB approval of forms (membership applications) before implementation. Annual Update to Equivalency Tables (2015) Adds alleles to HLA antigen dropdown options in UNet. Changes HLA-DPB, HLA-DQA, and HLA-DQB references in policy to HLA-DPB1, HLA-DQA1, and HLA-DQB1 Adds dropdown menus to Dr51, Dr52, Dr53 BOD approved, pending implementation, target date is second quarter of 2017

Committee Projects Histo Testing Guidance Document Result of Comprehensive Histocompatibility Rewrite project. Moves 28 sections of old policies and bylaws into a guidance document for member labs. Guidance document in final stages of revision. Anticipated submission to BOD for December meeting. Review of HLA Tables 2016 (DPB1) Building an unacceptable antigen tool into policy for DPB1 – Given the complexity and unique attributes of DPB1, this table will function differently than other equivalency tables. Subcommittee reviewing literature on epitopes to determine which ones to include Assessing possibility of developing a computer-assisted tool for helping determining DPB1 compatibility for patients with DPB1 antibody.

Committee Projects Addressing HLA Typing Errors in DonorNet® Committee working on process improvements to reduce/prevent critical HLA typing errors on donors/candidates resulting in incorrect match runs and organ allocation. As a number of “errors” are the result of transcriptional and parent/split calls, subcommittee is finalizing a memo to be sent to all HLA laboratories requesting increased awareness of such errors Subcommittee is reviewing options for programming changes to DonorNet® aimed at reducing errors. Suggestions include: duplicate data entry, “locked” HLA data fields once entry complete, “flags/alerts” to indicate potentially incorrect data.

Committee Projects Changes to KAS CPRA and Priority for Patients Undergoing Desensitization Building into KAS the ability for patients to maintain PRA priority points when undergoing a desensitization protocol Preliminary survey results showed favorable support for this concept Committee to determine what data to request to best define the problem and submit the project to the POC for approval

Questions? Robert Bray, PhD Committee Chair rbray@emory.edu Robert Hunter Committee Liaison robert.hunter@unos.org